Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

OSL:BAKKA - Euronext Oslo - FO0000000179 - Common Stock - Currency: NOK

485  +8.4 (+1.76%)

Fundamental Rating

5

BAKKA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Food Products industry. BAKKA has an excellent financial health rating, but there are some minor concerns on its profitability. BAKKA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BAKKA was profitable.
BAKKA had a positive operating cash flow in the past year.
BAKKA had positive earnings in each of the past 5 years.
In the past 5 years BAKKA always reported a positive cash flow from operatings.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

BAKKA's Return On Assets of 1.38% is on the low side compared to the rest of the industry. BAKKA is outperformed by 63.33% of its industry peers.
Looking at the Return On Equity, with a value of 2.25%, BAKKA is doing worse than 63.33% of the companies in the same industry.
BAKKA has a Return On Invested Capital (5.38%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BAKKA is in line with the industry average of 6.63%.
Industry RankSector Rank
ROA 1.38%
ROE 2.25%
ROIC 5.38%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 3.56%, BAKKA is in line with its industry, outperforming 51.67% of the companies in the same industry.
In the last couple of years the Profit Margin of BAKKA has declined.
The Operating Margin of BAKKA (16.45%) is better than 86.67% of its industry peers.
BAKKA's Operating Margin has declined in the last couple of years.
BAKKA has a Gross Margin of 70.36%. This is amongst the best in the industry. BAKKA outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of BAKKA has remained more or less at the same level.
Industry RankSector Rank
OM 16.45%
PM (TTM) 3.56%
GM 70.36%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

BAKKA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BAKKA remains at a similar level compared to 1 year ago.
The number of shares outstanding for BAKKA has been increased compared to 5 years ago.
The debt/assets ratio for BAKKA has been reduced compared to a year ago.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.96 indicates that BAKKA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of BAKKA (2.96) is better than 76.67% of its industry peers.
BAKKA has a debt to FCF ratio of 3.43. This is a good value and a sign of high solvency as BAKKA would need 3.43 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.43, BAKKA belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that BAKKA is not too dependend on debt financing.
BAKKA has a better Debt to Equity ratio (0.35) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.43
Altman-Z 2.96
ROIC/WACC0.65
WACC8.22%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 4.79 indicates that BAKKA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.79, BAKKA belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
BAKKA has a Quick Ratio of 1.24. This is a normal value and indicates that BAKKA is financially healthy and should not expect problems in meeting its short term obligations.
BAKKA's Quick ratio of 1.24 is fine compared to the rest of the industry. BAKKA outperforms 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 1.24
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

BAKKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
BAKKA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.36% yearly.
The Revenue has decreased by -3.70% in the past year.
BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.21% yearly.
EPS 1Y (TTM)-15.38%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-42.69%
Revenue 1Y (TTM)-3.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-13.91%

3.2 Future

BAKKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.37% yearly.
The Revenue is expected to grow by 10.85% on average over the next years. This is quite good.
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue Next Year1.63%
Revenue Next 2Y10.9%
Revenue Next 3Y10.85%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.68, which indicates a rather expensive current valuation of BAKKA.
BAKKA's Price/Earnings ratio is in line with the industry average.
BAKKA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.82.
A Price/Forward Earnings ratio of 10.66 indicates a reasonable valuation of BAKKA.
Based on the Price/Forward Earnings ratio, BAKKA is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, BAKKA is valued rather cheaply.
Industry RankSector Rank
PE 20.68
Fwd PE 10.66
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAKKA indicates a slightly more expensive valuation: BAKKA is more expensive than 60.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BAKKA is valued a bit cheaper than 61.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.84
EV/EBITDA 11.93
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)1.08
PEG (5Y)N/A
EPS Next 2Y26.38%
EPS Next 3Y26.37%

3

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.74%. Purely for dividend investing, there may be better candidates out there.
BAKKA's Dividend Yield is comparable with the industry average which is at 3.24.
Compared to an average S&P500 Dividend Yield of 2.39, BAKKA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BAKKA pays out 206.25% of its income as dividend. This is not a sustainable payout ratio.
BAKKA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP206.25%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (5/23/2025, 7:00:00 PM)

485

+8.4 (+1.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-26 2025-08-26
Inst Owners63%
Inst Owner ChangeN/A
Ins Owners16.05%
Ins Owner ChangeN/A
Market Cap28.80B
Analysts77.78
Price Target632.51 (30.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend13.43
Dividend Growth(5Y)3.15%
DP206.25%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.76%
Min EPS beat(2)-14.72%
Max EPS beat(2)-2.8%
EPS beat(4)0
Avg EPS beat(4)-23.06%
Min EPS beat(4)-51.09%
Max EPS beat(4)-2.8%
EPS beat(8)2
Avg EPS beat(8)-15.24%
EPS beat(12)3
Avg EPS beat(12)-13.78%
EPS beat(16)3
Avg EPS beat(16)-18.56%
Revenue beat(2)0
Avg Revenue beat(2)-15.8%
Min Revenue beat(2)-18.93%
Max Revenue beat(2)-12.67%
Revenue beat(4)0
Avg Revenue beat(4)-13.13%
Min Revenue beat(4)-18.93%
Max Revenue beat(4)-8.57%
Revenue beat(8)1
Avg Revenue beat(8)-8.51%
Revenue beat(12)4
Avg Revenue beat(12)-3.86%
Revenue beat(16)6
Avg Revenue beat(16)-3.44%
PT rev (1m)-7.49%
PT rev (3m)-13.05%
EPS NQ rev (1m)-28.06%
EPS NQ rev (3m)-39.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)-10.32%
Revenue NQ rev (3m)-26.64%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-7.96%
Valuation
Industry RankSector Rank
PE 20.68
Fwd PE 10.66
P/S 2.65
P/FCF 15.84
P/OCF 8.22
P/B 1.68
P/tB 2.82
EV/EBITDA 11.93
EPS(TTM)23.45
EY4.84%
EPS(NY)45.52
Fwd EY9.39%
FCF(TTM)30.61
FCFY6.31%
OCF(TTM)59.01
OCFY12.17%
SpS182.76
BVpS289.19
TBVpS171.73
PEG (NY)1.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.25%
ROCE 6.77%
ROIC 5.38%
ROICexc 5.46%
ROICexgc 7.47%
OM 16.45%
PM (TTM) 3.56%
GM 70.36%
FCFM 16.75%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexcg growth 3Y13.09%
ROICexcg growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.43
Debt/EBITDA 2.1
Cap/Depr 150.77%
Cap/Sales 15.54%
Interest Coverage 250
Cash Conversion 120.69%
Profit Quality 471.13%
Current Ratio 4.79
Quick Ratio 1.24
Altman-Z 2.96
F-Score5
WACC8.22%
ROIC/WACC0.65
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-42.69%
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-13.91%
Revenue Next Year1.63%
Revenue Next 2Y10.9%
Revenue Next 3Y10.85%
Revenue Next 5YN/A
EBIT growth 1Y-20.95%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year49.17%
EBIT Next 3Y32.47%
EBIT Next 5YN/A
FCF growth 1Y222.04%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y39.77%
OCF growth 3Y27.94%
OCF growth 5Y17.84%